Morpholino

MO1-vcla

ID

ZDB-MRPHLNO-100114-3

Name

MO1-vcla

Previous Names

Target

Sequence

5' - GTCTTGGTATGGAAAACTGGCATCC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-vcla

No data available

Phenotype

Phenotype resulting from MO1-vcla

Phenotype	Fish	Figures
blood circulation disrupted, abnormal	WT + MO1-vcla	Fig. 2 from Vogel et al., 2009
cardiac muscle cell action potential increased duration, abnormal	WT + MO1-vcla	Fig. S13 from Lundby et al., 2014
heart decreased contractility, abnormal	WT + MO1-vcla	Fig. 2 from Vogel et al., 2009
heart decreased functionality, abnormal	WT + MO1-vcla	Fig. S4 from Hirth et al., 2016
heart contraction decreased process quality, abnormal	WT + MO1-vcla	Fig. S4 from Hirth et al., 2016
pericardium edematous, abnormal	WT + MO1-vcla	Fig. S4 from Hirth et al., 2016 Fig. 2 from Vogel et al., 2009
sinus venosus increased accumulation blood, abnormal	WT + MO1-vcla	Fig. 2 from Vogel et al., 2009
skeletal muscle sarcomere decreased thickness, abnormal	WT + MO1-vcla	Fig. 3 from Vogel et al., 2009
skeletal muscle Z disc increased width, abnormal	WT + MO1-vcla	Fig. 3 from Vogel et al., 2009

Phenotype of all Fish created by or utilizing MO1-vcla

Phenotype	Fish	Conditions	Figures
heart contraction decreased process quality, abnormal	WT + MO1-vcla	control	Fig. S4 from Hirth et al., 2016
pericardium edematous, abnormal	WT + MO1-vcla	control	Fig. S4 from Hirth et al., 2016 Fig. 2 from Vogel et al., 2009
cardiac muscle cell action potential increased duration, abnormal	WT + MO1-vcla	standard conditions	Fig. S13 from Lundby et al., 2014
skeletal muscle Z disc increased width, abnormal	WT + MO1-vcla	standard conditions	Fig. 3 from Vogel et al., 2009
skeletal muscle sarcomere decreased thickness, abnormal	WT + MO1-vcla	standard conditions	Fig. 3 from Vogel et al., 2009
heart decreased functionality, abnormal	WT + MO1-vcla	control	Fig. S4 from Hirth et al., 2016
heart decreased contractility, abnormal	WT + MO1-vcla	standard conditions	Fig. 2 from Vogel et al., 2009
blood circulation disrupted, abnormal	WT + MO1-vcla	standard conditions	Fig. 2 from Vogel et al., 2009
sinus venosus increased accumulation blood, abnormal	WT + MO1-vcla	standard conditions	Fig. 2 from Vogel et al., 2009

Citations